A transcatheter aortic valve replacement procedure (TAVR) is a treatment procedure for patients with aortic stenosis who are too ill to undergo traditional aortic valve replacement surgery.
For more than five years, the TAVR team at MedStar Heart Institute at MedStar Washington Hospital Center have studied this procedure under clinical trials, to determine its safety and effectiveness. Our team of cardiologists, interventional cardiologists and cardiac surgeons has performed more than 300 TAVRs. Read more about our experience with TAVR.
In 2012, the Food Drug Administration (FDA) approved the use of the Edwards SAPIEN transcatheter heart valve for patients who are not candidates for traditional surgery.
If you suffer from severe aortic stenosis, an abnormal narrowing of the aortic valve, but cannot undergo traditional open-heart surgery, you may be a candidate for the TAVR procedure. Studies have shown that patients achieve better outcomes when they undergo a TAVR procedure than they do with medication alone.
Our TAVR team is at the forefront of innovation in heart care, involved in researching cardiac treatment options they can use to benefit you. When you come to the Heart Institute for treatment, you are in the hands of one of the most experienced cardiac teams in the nation. A highly specialized interventional cardiology team evaluates if you are a candidate for TAVR and performs the TAVR procedure, if appropriate.
Request an evaluation for the TAVR procedure. If you have any questions about TAVR, or if your heart condition changes a lot while you are waiting for the procedure, please call MedStar Heart Institute's TAVR Team, at 202-877-5975.